Christopher Reese

Mr. Christopher Reese

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
VJVictor De Jesus
Victor De Jesus
DBDeepak Bhandari
Deepak Bhandari
LZLuyu Zhang
Luyu Zhang
CRChristopher Reese
Christopher Reese
KCKimberly Capella
Kimberly Capella
BBBenjamin C Blount
Benjamin C Blount
Volatile organic compounds (VOCs) are ubiquitous in the environment. In the United States (U.S.), tobacco smoke is the major non-occupational source of exposure to many harmful VOCs. Exposure to VOCs can be assessed by measuring their urinary metabolites (VOCMs). The Population Assessment of Tobacco and Health (PATH) Study is a U.S. national longitudinal study of tobacco use in the adult and youth civilian non-institutionalized population. We measured 20 VOCMs in urine specimens from a subsample of adults in Wave 1 (W1) (2013–2014) to characterize VOC exposures among tobacco product users and non-users. We calculated weighted geometric means (GMs) and percentiles of each VOCM for exclusive combustible product users (smokers), exclusive electronic cigarette (e-cigarette) users, exclusive smokeless product users, and tobacco product never users. We produced linear regression models for six VOCMs with sex, age, race, and tobacco user group as predictor variables. Creatinine-ratioed levels of VOCMs from exposure to acrolein, crotonaldehyde, isoprene, acrylonitrile, and 1,3-butadiene were significantly higher in smokers than in never users. Small differences of VOCM levels among exclusive e-cigarette users and smokeless users were observed when compared to never users. Smokers showed higher VOCM concentrations than e-cigarette, smokeless, and never users. Urinary VOC metabolites are useful biomarkers of exposure to harmful VOCs.

18 May 2026 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
MNMahdokht Naghash
Mahdokht Naghash
RSRebecca L. Shaner
Rebecca L. Shaner
HPHossein Poustchi
Hossein Poustchi
GRGholamreza Roshandel
Gholamreza Roshandel
JBJulianne Cook Botelho
Julianne Cook Botelho
AEArash Etemadi
Arash Etemadi
Background: Opium consumption, a recognized carcinogen, is associated with lung cancer. However, the relative contributions of its potentially carcinogenic constituents to lung cancer risk remain unclear. Methods: We conducted a nested case–control study among opium users in the Golestan Cohort Study, including 53 incident lung cancer cases and 53 controls matched on age, sex, tobacco use, place of residence, and enrollment time. Urinary biomarkers of opioids, volatile organic compounds (VOC), polycyclic aromatic hydrocarbons (PAH), cotinine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and creatinine were measured in baseline samples. Adjusted logistic regression analyses, as well as mediation analyses, were used to evaluate the associations between biomarker concentrations and lung cancer incidence. Results: We found statistically significant associations between 3- and 6-glucuronide of morphine, as well as metabolites of acrylonitrile/ethylene oxide (2-hydroxyethyl mercapturic acid) and propylene oxide (2-hydroxypropyl mercapturic acid), and lung cancer among opium users, especially those who smoked opium. Associations between VOC metabolites and lung cancer were independent of opioid biomarkers, and mediation analysis showed no evidence that VOCs mediate the effects of opioid biomarkers on lung cancer. No associations were observed for PAH biomarkers, cotinine and NNAL. Conclusions: Our findings provide biochemical evidence supporting the association between opium use and lung cancer, highlighting independent mechanisms related to both opioid and non-opioid components of opium, with varying effects by route of use. Impact: Opioids and chemical constituents produced during opium consumption must be considered in cancer risk assessment. See related In the Spotlight, p. 1801

15 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
AMAlexander Mayer
Alexander Mayer
MCMiriam M. Calkins
Miriam M. Calkins
DUDerek J. Urwin
Derek J. Urwin
SBStephen J. Bertke
Stephen J. Bertke
CTChristine Toennis
Christine Toennis
JBJefferey Burgess
Jefferey Burgess
Firefighters suppressing wildland urban interface (WUI) fires may be exposed to smoke from burning vegetation as well as structures and vehicles. To better understand firefighters’ internal dose exposures in the WUI environment, 250 firefighters from Southern California were enrolled into the Fire Fighter Cancer Cohort Study (FFCCS) in 2019, providing urine samples at enrollment and post-fire. One-hundred and twenty-five post-fire samples were collected from 89 participants. Samples were analyzed for metal(loid)s and metabolites of polycyclic aromatic hydrocarbons (PAHs), volatile organic compounds (VOCs), and organophosphate esters (OPEs). We assessed the difference between creatinine-corrected urine concentrations for each chemical at enrollment compared with post-fire, controlling for the individual participant. We also compared these concentrations to the general U.S. population concentrations from the National Health and Nutrition Examination Survey (NHANES) and the American Conference of Governmental Industrial Hygienists Biological Exposure Indices (BEIs) when available. All seven PAH and 11 VOC metabolite concentrations increased significantly from enrollment to post-fire. Diphenyl phosphate, antimony, and cadmium also significantly increased from enrollment to post-fire. Maximum post-fire concentrations in the firefighters also exceeded the BEI for 1-hydroxyprene and trans,trans-muconic acid (a metabolite of benzene). Firefighters assigned to structure defense had significantly higher increases in PAH metabolites compared to those assigned to wildland firefighting tasks. Among all firefighting ranks, hand crew members showed the highest increases in certain VOC metabolites (i.e., acrylamide and xylenes). Future studies could combine personal sampling with the collection of detailed PPE usage to develop effective PPE practices and decontamination strategies during WUI fire responses.

18 March 2026 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Closed access
PDF file
MNMahdi Nalini
Mahdi Nalini
KOKatie O'Brien
Katie O'Brien
ACAntonia M Calafat
Antonia M Calafat
LWLanqing Wang
Lanqing Wang
JFJun Feng
Jun Feng
AEArash Etemadi
Arash Etemadi
Background: The constituents of tobacco smoke that specifically contribute to lung cancer risk have yet to be fully identified. We evaluated associations between biomarkers of potentially harmful constituents—polycyclic aromatic hydrocarbons, tobacco-specific nitrosamines, nicotine, and volatile organic compounds—and lung cancer incidence among US women. Methods: In a case-cohort study nested within the Sister Study (women aged 35-74 years at baseline, enrolled 2003-2009), data were obtained for a random subcohort and all remaining incident lung cancers through September 2017 (median follow-up = 9.6 years), stratified by race and ethnicity (Hispanic, non-Hispanic Black, non-Hispanic White, others) and smoking status (current, former, never). The analytic sample included 356 cases and 433 noncases. We quantified 30 biomarkers in baseline urine samples and calculated hazard ratios (HRs) for associations between 1-unit increase in biomarker concentrations (log-scale) and lung cancer incidence using weighted Cox regression models adjusted for urinary creatinine and demographic, health, and lifestyle factors. Results: Among women who were currently smoking at enrollment, positive associations were observed for biomarkers of polycyclic aromatic hydrocarbons (naphthalene, phenanthrene, pyrene, fluorene; HRs = 1.4-5.3), tobacco-specific nitrosamines (particularly 4-[methylnitrosamino]-1-[3-pyridyl]-1-butanone [nicotine-derived nitrosamine ketone]; HRs = 1.3-2.2), and volatile organic compounds (xylene, acrylamide, acrylonitrile, 1,2-dibromoethane and/or vinyl-chloride and/or ethylene-oxide and/or acrylonitrile, acrolein, styrene and/or ethylbenzene, benzene, dimethylformamide and/or methylisocyanate, 1,3-butadiene, crotonaldehyde, isoprene; HRs = 1.6-4.4). Associations with biomarkers of most polycyclic aromatic hydrocarbons, nicotine-derived nitrosamine ketone, xylene, and dimethylformamide and/or methylisocyanate remained after additional adjustment for smoking frequency, duration, and nicotine metabolites. In women who did not smoke, positive associations were observed for styrene and/or ethylbenzene and dimethylformamide and/or methylisocyanate biomarkers. Conclusion: Exposure to polycyclic aromatic hydrocarbons, tobacco-specific nitrosamines, and several volatile organic compounds through tobacco smoking were associated with increased lung cancer risk among women.

2 November 2026
Verified
Other
Open access
MNMahdokht Naghash
Mahdokht Naghash
RSRebecca L. Shaner
Rebecca L. Shaner
HPHossein Poustchi
Hossein Poustchi
GRGholamreza Roshandel
Gholamreza Roshandel
JBJulianne Cook Botelho
Julianne Cook Botelho
AEArash Etemadi
Arash Etemadi
Supplementary Table S1 shows Biomarkers related to opium exposure and their coefficients of variation

2 November 2026
Verified
Other
Open access
MNMahdokht Naghash
Mahdokht Naghash
RSRebecca L. Shaner
Rebecca L. Shaner
HPHossein Poustchi
Hossein Poustchi
GRGholamreza Roshandel
Gholamreza Roshandel
JBJulianne Cook Botelho
Julianne Cook Botelho
AEArash Etemadi
Arash Etemadi
Supplementary Figure S3 shows Pearson correlation coefficients of opioid and nonopioid biomarkers related to opium use in the total sample. Colors correspond to the color key on the right, showing the strength and direction of correlation. Squares marked with an “x” show statistically non-significant correlations.